QSS
ALXN
Quantitative Systematic Strategies’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,095
| Closed | -$752K | – | 437 |
|
|
2021
Q2 | $752K | Sell |
4,095
-5,645
| -58% | -$1.04M | 0.26% | 128 |
|
|
2021
Q1 | $1.49M | Buy |
9,740
+5,869
| +152% | +$897K | 0.23% | 138 |
|
|
2020
Q4 | $605K | Buy |
+3,871
| New | +$605K | 0.09% | 350 |
|
|
2019
Q3 | – | Sell |
-2,192
| Closed | -$287K | – | 625 |
|
|
2019
Q2 | $287K | Buy |
+2,192
| New | +$287K | 0.05% | 341 |
|
|
2018
Q3 | – | Sell |
-2,464
| Closed | -$306K | – | 850 |
|
|
2018
Q2 | $306K | Sell |
2,464
-850
| -26% | -$106K | 0.06% | 459 |
|
|
2018
Q1 | $369K | Buy |
3,314
+861
| +35% | +$95.9K | 0.08% | 400 |
|
|
2017
Q4 | $293K | Buy |
2,453
+114
| +5% | +$13.6K | 0.07% | 393 |
|
|
2017
Q3 | $328K | Sell |
2,339
-968
| -29% | -$136K | 0.09% | 313 |
|
|
2017
Q2 | $405K | Buy |
3,307
+1,384
| +72% | +$169K | 0.1% | 271 |
|
|
2017
Q1 | $233K | Sell |
1,923
-1,075
| -36% | -$130K | 0.07% | 300 |
|
|
2016
Q4 | $370K | Sell |
2,998
-382
| -11% | -$47.1K | 0.15% | 231 |
|
|
2016
Q3 | $406K | Sell |
3,380
-6,343
| -65% | -$762K | 0.15% | 218 |
|
|
2016
Q2 | $1.11M | Buy |
+9,723
| New | +$1.11M | 0.52% | 24 |
|
|
2015
Q3 | – | Sell |
-3,393
| Closed | -$604K | – | 566 |
|
|
2015
Q2 | $604K | Sell |
3,393
-3,036
| -47% | -$540K | 0.13% | 259 |
|
|
2015
Q1 | $1.15M | Buy |
6,429
+4,166
| +184% | +$746K | 0.31% | 101 |
|
|
2014
Q4 | $419K | Buy |
+2,263
| New | +$419K | 0.17% | 181 |
|